<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-8NIUA3FI</identifier><date>2013</date><creator>Anderluh, Franc</creator><creator>Možina, Barbara</creator><creator>Oblak, Irena</creator><creator>Ocvirk, Janja</creator><creator>Velenik, Vaneja</creator><relation>documents/doc/8/URN_NBN_SI_doc-8NIUA3FI_001.pdf</relation><relation>documents/doc/8/URN_NBN_SI_doc-8NIUA3FI_001.txt</relation><format format_type="issue">2</format><format format_type="volume">47</format><format format_type="type">article</format><format format_type="extent">str. 138-144, IV</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">1507963</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-8NIUA3FI</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">danka</subject><subject language_type_id="slv">metaloproteini</subject><subject language_type_id="eng">radiochemotherapy</subject><subject language_type_id="slv">radiokemoterapija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">rectal cancer</subject><subject language_type_id="eng">tissue inhibitor of metalloproteinases</subject><title>The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperattive radiochemotherapy in patients with rectal cancer</title></Record>